ZipLine Medical Inc.
A suture-like outcome at the speed of staples
This article was originally published in Start Up
Executive Summary
For many years, non-absorbable and absorbable sutures and staples have been the primary method of closing the external skin layer. Both types of devices provide good incision closure to promote wound healing, but they have drawbacks. There hasn't been much innovation in incision closure over the last decade, but now, innovative companies are working to address concerns with the gold standards. ZipLine Medical Inc. hopes to be at the forefront of this evolution with a noninvasive, external skin closure system intended as an alternative to sutures and staples that decreases operating time, heals the wound in a uniform manner with minimum skin stress and a much-improved aesthetic result and is easily removed by the patient at home.
You may also be interested in...
Surgical Incision Closure: Start-Ups Address A Megatrend In Health Care
Medtech start-ups are working to develop next-generation incision closure devices that address the shortfalls of gold standard sutures and staples. We profile three hopefuls in this issue: EndoEvolution, ZipLine Medical and ZSX Medical.
VasoStitch Inc.
Delivering valve devices to a structurally damaged heart through the femoral artery can be a tricky proposition. Cardiologists normally gain access through a large incision and employ balloons to increase the diameter of the aperture. Problems can arise when trying to close the hole at the end of the procedure. New technology from VasoStitch Inc. allows for simpler and safer access and closure of catheter-based interventions for minimally invasive valve replacement and repair. The start-up’s two devices, yet to be branded, are for accessing the heart through the femoral artery (transfemorally) and the chest wall (transapically), respectively